Circulating Tumor DNA for Customisation of Tumor Immunotherapy: Technology Advance and Clinical Evidence
Circulating tumour DNA (ctDNA) in blood is now used in a less invasive way to guide personalised cancer therapy. Several blood tests can be conducted on ctDNA to determine whether there is a distant spread of cancer cells, discover microscopic cancer cells remaining after surgery, and observe how the immune system resp...